RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-15.48%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$504M
AUM Growth
+$504M
(-24%)
Cap. Flow
-$64.4M
Cap. Flow
% of AUM
-12.78%
Top 10 Holdings %
Top 10 Hldgs %
27.49%
Holding
102
New
6
Increased
45
Reduced
33
Closed
10
Top Buys
| 1 |
Biogen
BIIB
|
$9.89M |
| 2 |
Alkermes
ALKS
|
$8.44M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$5.94M |
| 4 |
Gilead Sciences
GILD
|
$5.14M |
| 5 |
Incyte
INCY
|
$4.35M |
Top Sells
| 1 |
Perrigo
PRGO
|
$10.7M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$9.01M |
| 3 |
Medtronic
MDT
|
$8.4M |
| 4 |
HNT
HEALTH NET INC
HNT
|
$8.35M |
| 5 |
UnitedHealth
UNH
|
$7.86M |
Sector Composition
| 1 | Healthcare | 93.13% |
| 2 | Financials | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cardinal Health
CAH
$35.5B
| $7.54M | 1.5% | 92,000 -12,000 | -12% | -$983K |
|
|
AET
27
DELISTED
Aetna Inc
AET
| $7.53M | 1.49% | 67,000 -37,000 | -36% | -$4.16M |
|
28
AbbVie
ABBV
$372B
| $7.43M | 1.47% | 130,000 -116,000 | -47% | -$6.63M |
|
|
ENDP
29
DELISTED
Endo International plc
ENDP
| $7.32M | 1.45% | 260,000 +144,000 | +124% | +$4.05M |
|
|
ESRX
30
DELISTED
Express Scripts Holding Company
ESRX
| $7.28M | 1.45% | 106,000 +32,000 | +43% | +$2.2M |
|
31
Nektar Therapeutics
NKTR
$568M
| $7.22M | 1.43% | 525,000 -56,000 | -10% | -$770K |
|
32
Amgen
AMGN
$155B
| $6.75M | 1.34% | 45,000 -37,000 | -45% | -$5.55M |
|
33
Elevance Health
ELV
$71.8B
| $6.53M | 1.3% | 47,000 -41,000 | -47% | -$5.7M |
|
34
McKesson
MCK
$85.4B
| $6.29M | 1.25% | 40,000 -19,000 | -32% | -$2.99M |
|
35
Vertex Pharmaceuticals
VRTX
$100B
| $6.2M | 1.23% | 78,000 +22,000 | +39% | +$1.75M |
|
36
Cooper Companies
COO
$13.4B
| $6.16M | 1.22% | 40,000 +3,000 | +8% | +$462K |
|
37
Cencora
COR
$56.5B
| $5.45M | 1.08% | 63,000 +17,000 | +37% | +$1.47M |
|
38
DexCom
DXCM
$29.5B
| $5.09M | 1.01% | 75,000 -30,000 | -29% | -$2.04M |
|
|
CPHD
39
DELISTED
Cepheid Inc
CPHD
| $5M | 0.99% | 150,000 +75,000 | +100% | +$2.5M |
|
40
Humana
HUM
$36.5B
| $4.94M | 0.98% | 27,000 -34,000 | -56% | -$6.22M |
|
41
Edwards Lifesciences
EW
$47.8B
| $4.85M | 0.96% | 55,000 +6,000 | +12% | +$529K |
|
|
CERN
42
DELISTED
Cerner Corp
CERN
| $4.56M | 0.9% | 86,000 +4,000 | +5% | +$212K |
|
|
KERX
43
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $4.44M | 0.88% | 950,000 -283,000 | -23% | -$1.32M |
|
|
ZLTQ
44
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $4.35M | 0.86% | 160,000 +32,000 | +25% | +$869K |
|
45
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.33M | 0.86% | 12,000 -9,000 | -43% | -$3.24M |
|
46
Community Health Systems
CYH
$387M
| $4.17M | 0.83% | 225,000 +130,000 | +137% | +$2.41M |
|
47
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.12M | 0.82% | 270,000 -18,000 | -6% | -$275K |
|
48
Halozyme
HALO
$8.56B
| $4.08M | 0.81% | 431,000 +21,000 | +5% | +$199K |
|
49
Jazz Pharmaceuticals
JAZZ
$7.75B
| $3.92M | 0.78% | 30,000 -12,000 | -29% | -$1.57M |
|
|
ARIA
50
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.83M | 0.76% | 600,000 +170,000 | +40% | +$1.09M |
|